Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;53(12):850-858.
doi: 10.1136/jmedgenet-2016-103909. Epub 2016 Jun 29.

De novo mutations of KIAA2022 in females cause intellectual disability and intractable epilepsy

Iris M de Lange  1 , Katherine L Helbig  2 , Sarah Weckhuysen  3   4   5 , Rikke S Møller  6   7 , Milen Velinov  8   9 , Natalia Dolzhanskaya  8   9 , Eric Marsh  10 , Ingo Helbig  10 , Orrin Devinsky  11 , Sha Tang  2 , Heather C Mefford  12 , Candace T Myers  12 , Wim van Paesschen  13 , Pasquale Striano  14 , Koen van Gassen  1 , Marjan van Kempen  1 , Carolien G F de Kovel  1 , Juliette Piard  15 , Berge A Minassian  16 , Marjan M Nezarati  17 , André Pessoa  18 , Aurelia Jacquette  19 , Bridget Maher  20   21 , Simona Balestrini  20   21 , Sanjay Sisodiya  20   21 , Marie Therese Abi Warde  22   23 , Anne De St Martin  22   23 , Jamel Chelly  23   24 ; EuroEPINOMICS-RES MAE working group; Ruben van 't Slot  1 , Lionel Van Maldergem  15 , Eva H Brilstra  1 , Bobby P C Koeleman  1
Affiliations

De novo mutations of KIAA2022 in females cause intellectual disability and intractable epilepsy

Iris M de Lange et al. J Med Genet. 2016 Dec.

Abstract

Background: Mutations in the KIAA2022 gene have been reported in male patients with X-linked intellectual disability, and related female carriers were unaffected. Here, we report 14 female patients who carry a heterozygous de novo KIAA2022 mutation and share a phenotype characterised by intellectual disability and epilepsy.

Methods: Reported females were selected for genetic testing because of substantial developmental problems and/or epilepsy. X-inactivation and expression studies were performed when possible.

Results: All mutations were predicted to result in a frameshift or premature stop. 12 out of 14 patients had intractable epilepsy with myoclonic and/or absence seizures, and generalised in 11. Thirteen patients had mild to severe intellectual disability. This female phenotype partially overlaps with the reported male phenotype which consists of more severe intellectual disability, microcephaly, growth retardation, facial dysmorphisms and, less frequently, epilepsy. One female patient showed completely skewed X-inactivation, complete absence of RNA expression in blood and a phenotype similar to male patients. In the six other tested patients, X-inactivation was random, confirmed by a non-significant twofold to threefold decrease of RNA expression in blood, consistent with the expected mosaicism between cells expressing mutant or normal KIAA2022 alleles.

Conclusions: Heterozygous loss of KIAA2022 expression is a cause of intellectual disability in females. Compared with its hemizygous male counterpart, the heterozygous female disease has less severe intellectual disability, but is more often associated with a severe and intractable myoclonic epilepsy.

Keywords: KIAA2022; Clinical genetics; Epilepsy and seizures; X-linked.

PubMed Disclaimer

Conflict of interest statement

KLH and ST are employed by and receive a salary from Ambry Genetics. BAM was supported by Genome Canada and the Ontario Brain Institute. BM, SB and SS are funded by the Epilepsy Society and Wellcome Trust. Part of this work was undertaken at University College London Hospitals, which received a proportion of funding from the NIHR Biomedical Research Centres funding scheme.

Figures

Figure 1
Figure 1
Genomic organisation of KIAA2022 and location of mutations. Figure shows schematic presentation of known exon–intron organisation of KIAA2022. Exon size is at a scale apart from exon 4, for which the arrow indicates the continued size. Untranslated regions are indicated by grey colour, and the coding regions are indicated by blue colour. The boxes indicate the location and identity of the (previously) observed mutations in female (lower/red boxes) and previously reported mutations in male patients (upper/green boxes).
Figure 2
Figure 2
Relative expression of KIAA2022 in four cases versus female controls. Y-axis gives the ratio of positive droplets for KIAA2022 vs GAPDH; experiment was done in triplicate. 95% CIs are indicated by error bars.
See this image and copyright information in PMC

References

    1. Cantagrel V, Lossi A-M, Boulanger S, Depetris D, Mattei M-G, Gecz J, Schwartz CE, Van Maldergem L, Villard L. Disruption of a new X linked gene highly expressed in brain in a family with two mentally retarded males. J Med Genet 2004;41:736–42. 10.1136/jmg.2004.021626 - DOI - PMC - PubMed
    1. Van Maldergem L, Hou Q, Kalscheuer VM, Rio M, Doco-Fenzy M, Medeira A, de Brouwer APM, Cabrol C, Haas SA, Cacciagli P, Moutton S, Landais E, Motte J, Colleaux L, Bonnet C, Villard L, Dupont J, Man H-Y. Loss of function of KIAA2022 causes mild to severe intellectual disability with an autism spectrum disorder and impairs neurite outgrowth. Hum Mol Genet 2013;22:3306–14. 10.1093/hmg/ddt187 - DOI - PMC - PubMed
    1. Kuroda Y, Ohashi I, Naruto T, Ida K, Enomoto Y, Saito T, Nagai J, Wada T, Kurosawa K. Delineation of the KIAA2022 mutation phenotype: two patients with X-linked intellectual disability and distinctive features. Am J Med Genet Part A 2015;167A:1349–53. 10.1002/ajmg.a.37002 - DOI - PubMed
    1. Soden SE, Saunders CJ, Willig LK, Farrow EG, Smith LD, Petrikin JE, LePichon J-B, Miller NA, Thiffault I, Dinwiddie DL, Twist G, Noll A, Heese BA, Zellmer L, Atherton AM, Abdelmoity AT, Safina N, Nyp SS, Zuccarelli B, Larson IA, Modrcin A, Herd S, Creed M, Ye Z, Yuan X, Brodsky RA, Kingsmore SF. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med 2014;6:265ra168 10.1126/scitranslmed.3010076 - DOI - PMC - PubMed
    1. Charzewska A, Rzońca S, Janeczko M, Nawara M, Smyk M, Bal J, Hoffman-Zacharska D. A duplication of the whole KIAA2022 gene validates the gene role in the pathogenesis of intellectual disability and autism. Clin Genet 2015;88:297–9. 10.1111/cge.12528 - DOI - PubMed